论文信息 - Time Since Rituximab Treatment Is Essential for Developing a Humoral Response to COVID-19 mRNA Vaccines in Patients With Rheumatic Diseases - 字舞流文

Time Since Rituximab Treatment Is Essential for Developing a Humoral Response to COVID-19 mRNA Vaccines in Patients With Rheumatic Diseases

E. Hauge | C. Erikstrup | A. Troldborg | L. Bartels | M. Thomsen | S. Mikkelsen | C. Ammitzbøll | M. Hermansen | J. B. Andersen | A. Johannsen | C. E. Mistegaard | S. R. Vils